Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1/2 2Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 89Leukemia 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma 26Leukemia, Erythroblastic, Acute 19Leukemia, Myelomonocytic, Acute 18Leukemia, Monocytic, Acute 18Leukemia, Megakaryoblastic, Acute 18Congenital Abnormalities 13Burkitt Lymphoma 13Lymphoma, Large B-Cell, Diffuse 12Myelodysplastic Syndromes 10Lymphoma, Non-Hodgkin 10Anemia, Refractory, with Excess of Blasts 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma, Follicular 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Eosinophilic, Acute 6Recurrence 5Myeloproliferative Disorders 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Promyelocytic, Acute 5Leukemia, Biphenotypic, Acute 5Leukemia, Basophilic, Acute 5Hodgkin Disease 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Multiple Myeloma 4

Interventions

Early Intervention, Educational 2Cytarabine 2Antibodies 2vedolizumab 1hydrocortisone hemisuccinate 1Whole-Body Irradiation 1Valacyclovir 1Transplantation 1Thioguanine 1Therapeutics 1Stem Cell Transplantation 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Drug Therapy 1Daunorubicin 1Calcineurin Inhibitors 1Biopsy 1Asparaginase 1Acyclovir 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Myelomonocytic, Juvenile × Cytarabine × Clear all
NCT00047268 2013-09-17

Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00003593 2013-06-27

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Children's Oncology Group

Phase 3 Completed
254 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡